232 related articles for article (PubMed ID: 2370692)
21. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
22. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
23. Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model.
Quadri SM; Siddiqui A; Klein JL; Vriesendorp HM
Nucl Med Biol; 1995 May; 22(4):413-23. PubMed ID: 7550017
[TBL] [Abstract][Full Text] [Related]
24. Improved radioimaging and tumor localization with monoclonal F(ab')2.
Wahl RL; Parker CW; Philpott GW
J Nucl Med; 1983 Apr; 24(4):316-25. PubMed ID: 6339689
[TBL] [Abstract][Full Text] [Related]
25. Time course localization of immunoglobulin M monoclonal antibody and its fragments in leukemic tumor-bearing mice.
Maillet T; Roche AC; Thérain F; Monsigny M
Cancer Immunol Immunother; 1985; 19(3):177-82. PubMed ID: 3924394
[TBL] [Abstract][Full Text] [Related]
26. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
Colapinto EV; Humphrey PA; Zalutsky MR; Groothuis DR; Friedman HS; de Tribolet N; Carrel S; Bigner DD
Cancer Res; 1988 Oct; 48(20):5701-7. PubMed ID: 3167830
[TBL] [Abstract][Full Text] [Related]
27. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
[TBL] [Abstract][Full Text] [Related]
28. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
29. Radioimaging of experimental glioma grafts using F (ab')2-fragments of monoclonal antibodies.
Stavrou D; Glässner H; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1986; 6(5):897-903. PubMed ID: 3800333
[TBL] [Abstract][Full Text] [Related]
30. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
[TBL] [Abstract][Full Text] [Related]
32. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
34. [Biodistribution of radiolabeled F(ab')2 fragment of monoclonal antibody Nd2 and gamma-interferon enhancement on tumor localization in nude mice with human pancreatic tumor xenografts].
Kondo Y
Nihon Geka Gakkai Zasshi; 1995 Feb; 96(2):97-105. PubMed ID: 7708049
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
36. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
37. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.
Buchegger F; Chalandon Y; Pèlegrin A; Hardman N; Mach JP
J Nucl Med; 1991 Jul; 32(7):1414-21. PubMed ID: 2066798
[TBL] [Abstract][Full Text] [Related]
39. A cross-linked monoclonal antibody fragment for improved tumor targeting.
Stalteri MA; Mather SJ
Bioconjug Chem; 1995; 6(2):179-86. PubMed ID: 7599261
[TBL] [Abstract][Full Text] [Related]
40. A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.
Sandström K; Haylock AK; Spiegelberg D; Qvarnström F; Wester K; Nestor M
Int J Oncol; 2012 May; 40(5):1525-32. PubMed ID: 22307465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
